✦ LIBER ✦

4.19 Prediction of Poor Outcome in Chronic Lymphocytic Leukemia Patients treated with FCR (Fludarabine, Cyclophosphamide, Rituximab) in the CLL8 Trial of the German CLL Study Group

✍ Scribed by Anna Fink; Raymonde Busch; Natali Pflug; Sebastian Boettcher; Dirk Winkler; Andreas Buehler; Matthias Ritgen; Kirsten Fischer; Barbara Eichhorst; Clemens-Martin Wendtner; Myriam Mendila; Michael K. Wenger; Hartmut Doehner; Michael Kneba; Stephan Stilgenbauer; Michael Hallek

Book ID: 119218932
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 115 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-Related Quality of Life in Younge

✍ Eichhorst, B. F.; Busch, R.; Obwandner, T.; Kuhn-Hallek, I.; Herschbach, P.; Hal 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 191 KB

5.40 Rituximab Maintenance in Patients w

5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)

✍ Francesc Bosch; Pau Abrisqueta; Neus Villamor; María José Terol; Eva González-Ba 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 250 KB

Allogeneic stem cell transplantation pro

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

✍ Dreger, P.; Dohner, H.; Ritgen, M.; Bottcher, S.; Busch, R.; Dietrich, S.; Bunje 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 326 KB

Consolidation with alemtuzumab in patien

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)

✍ Wendtner, C-M; Ritgen, M; Schweighofer, C D; Fingerle-Rowson, G; Campe, H; Jäger 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

The Addition of Rituximab to Fludarabine

The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia

✍ Amit Mahipal; Mark Weiss 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 80 KB

Bendamustine in Combination With Rituxim

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Bottcher, S.; Bahlo, J.; Schubert, J.; Pflug 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB